person

Lija M.

Country
Latvia
Department
Private Practice

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
144
Sites with multiple studies

Has run more than one trial at 144 of 788 partner sites.

Specializations

Cardiovascular Disease Management

The investigator specializes in treating hypercholesterolemia and managing lipid disorders, with particular emphasis on developing innovative therapeutic approaches for patients who require additional cholesterol management beyond standard treatments.

  • Advanced Lipid Management
  • Cholesterol Reduction Strategies
  • Cardiovascular Risk Prevention

Their research encompasses the evaluation of novel therapeutic agents for improving lipid profiles in patients with challenging cholesterol management needs.

Stroke Prevention

The investigator focuses on preventing stroke and systemic embolism in patients with atrial fibrillation. Their work involves evaluating advanced therapeutic options for patients at risk of stroke-related complications.

  • Atrial Fibrillation Management
  • Anticoagulation Therapy
  • Thrombosis Prevention

Their expertise extends to investigating bleeding risk management and optimizing anticoagulation strategies in cardiac patients.

Quality of Life Assessment

The investigator studies the impact of cardiovascular treatments on patient quality of life, particularly in the context of long-term therapy for chronic cardiovascular conditions.

  • Treatment Effectiveness Evaluation
  • Patient Outcome Assessment
  • Therapeutic Impact Analysis

Their research includes comprehensive evaluation of both clinical efficacy and patient-reported outcomes in cardiovascular therapeutics.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.